Chronic inducible urticaria (CIndU) includes conditions where hives develop after a specific physical trigger. Two common forms are cold-induced urticaria and symptomatic dermographism.
People with ColdU may develop hives when exposed to cold air, water, or objects. Those with symptomatic dermographism may notice raised, itchy welts when their skin is rubbed or scratched. These reactions can be painful and frustrating, especially when symptoms persist despite daily antihistamines.
The EMBARQ ColdU and SD Study is exploring a new investigational injectable treatment for adults living with these conditions. Phase 3 trials help researchers better understand whether a therapy is safe and effective before it may become widely available.
Clinical trials are carefully monitored, and participants can withdraw at any time. For many individuals, joining a study is a way to help advance research while receiving study-related care and monitoring.